A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

This study has been completed.

Sponsor:

Information provided by:

Mylan Bertek Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00145171

First received: September 2, 2005

Last updated: NA

Last verified: November 2002

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2002
Estimated Primary Completion Date:	No date given